SciCombinator

Discover the most talked about and latest scientific content & concepts.

The Essential Medicinal Chemistry of Curcumin

OPEN Journal of medicinal chemistry | 12 Jan 2017

KM Nelson, JL Dahlin, J Bisson, J Graham, GF Pauli and MA Walters
Abstract
Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.
Tweets*
485
Facebook likes*
32
Reddit*
6
News coverage*
63
Blogs*
25
SC clicks
0
Concepts
Alzheimer's disease, Clinical research, Medicine, Epidemiology, The Canon of Medicine, Avicenna, Clinical trial, Pharmacology
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com